Location History:
- Portola Valley, CA (US) (1992 - 2012)
- Woodside, CA (US) (2024)
Company Filing History:
Years Active: 1992-2024
Title: Innovations of Stephen B Kahl: Pioneering Cancer Treatment Solutions
Introduction
Stephen B Kahl, an accomplished inventor based in Portola Valley, CA, has made significant contributions to the field of medical innovations, particularly in cancer treatment. With a total of six patents to his name, his inventions focus on advanced methods for delivering anti-cancer agents to nerve cells, offering promising avenues for improving patient care.
Latest Patents
Stephen's latest patents showcase groundbreaking technologies aimed at enhancing the efficacy of cancer treatments. One notable patent involves “Conjugates for delivering an anti-cancer agent to nerve cells: methods of use and methods of making thereof.” This invention outlines conjugate compounds that include a protein, peptide, or peptidomimetic selectively binding to neurotrophin receptors, covalently linking an anti-cancer agent to improve delivery to nerve cells. It emphasizes compositions and methods that are particularly useful for treating conditions such as optic pathway glioma and other related cancers.
Another recent patent details “Compounds for delivery of therapeutic and imaging moieties to nerve cells.” This innovation comprises a compound characterized by a binding agent that mediates absorption by nerve cells alongside a non-cytotoxic moiety that provides therapeutic or imaging functions upon absorption. The patent highlights applications for treating viral infections and pain, as well as for nerve cell labeling techniques.
Career Highlights
Stephen B Kahl's career is marked by significant affiliations with leading research institutions, including the University of California and Manzanita Pharmaceuticals, Inc. His tenure at these organizations allowed him to collaborate with eminent researchers, enhancing the scope and impact of his inventions.
Collaborations
Stephen has worked alongside distinguished colleagues such as Constance A McKee and Myoung-Seo Koo. These collaborations have been instrumental in propelling his research forward and achieving substantial breakthroughs in the field of cancer therapeutics.
Conclusion
In summary, Stephen B Kahl exemplifies innovation in medical science through his patented inventions that advance cancer treatment methodologies. His work not only reflects his dedication as an inventor but also highlights the potential for transformative changes in how cancer therapies are delivered, showcasing his significant contributions to both the scientific community and patient care.